FOXD2 and colorectal carcinoma: Our findings revealed that the expression of TFs including NR3C2, KLF4, CASZ1, FOXD2, ATOH1, and RORC in CRC samples was much lower than in normal samples and that their increased expression was linked to the good prognosis of patients.